[Anticholinergic treatment of Parkinson's disease (author's transl)].

Abstract

Anticholinergic drugs retain their place even today in the treatment of Parkinson's disease in spite of the considerable success achieved by means of stereotactic surgery and substitution therapy with dopa or dopa derivatives. An investigation was made on 44 patients suffering from Parkinson's disease treated with the new anticholinergic drug, Sormodren (Knoll). Sormodren showed a selective action on the hyperkinetic and autonomic symptoms of this disease of the extrapyramidal system. Tolerance was good, no serious side effects being observed.

• Authors: P W Ascher
• Journal: Wiener klinische Wochenschrift (Wien Klin Wochenschr) Vol. 88 Issue 19 Pg. 641-6 (Oct 15 1976) ISSN: 0043-5325 [Print] Austria
• Vernacular Title: Das anticholinergische Behandlungsprinzip des Morbus Parkinson
• PMID: 790774 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Parasympatholytics

Topics

• Adult
• Aged
• Chemical Phenomena
• Chemistry
• Clinical Trials as Topic
• Drug Evaluation
• Female
• Humans
• Male
• Middle Aged
• Parasympatholytics (administration & dosage, therapeutic use)
• Parkinson Disease (drug therapy, surgery)
• Stereotaxic Techniques